Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
J Infect Dev Ctries ; 14(10): 1098-1105, 2020 Oct 31.
Article de Anglais | MEDLINE | ID: mdl-33175702

RÉSUMÉ

The novel coronavirus has become a global risk because of its massive transmission and high rates of mutation. Efficient clinical management remains a challenge in combatting the severe acute respiratory syndrome caused by this virulent strain. This contagious disease is new to the people of Bangladesh. The country is at high risk of spreading the coronavirus infection particularly because of its high population density. Significant morbidity and mortality have been observed for the quick transmission of this virus since March 8, 2020. The basic objective of this article is to analyze the preparedness of Bangladesh, given its constraints and limitations, to cope with the rapid spread of COVID-19 infection. In doing so, it summarizes the origin of coronavirus, epidemiology, mode of transmission, diagnosis, treatment, prevention and control of the disease. Although many steps have been taken by the Government and the private sector of Bangladesh to create awareness about measures needed to prevent the deadly infections, many people are unaware of and reluctant to accept the prescribed rules. Inadequacy of diagnostic facilities and limitations of clinical care and health care services were major constraints faced in treating COVID-19 infected people in Bangladesh. Greater compliance by the people in following the suggested measures may help reduce the rapid spread of the disease and overcome the challenges faced by this pandemic.


Sujet(s)
Infections à coronavirus/épidémiologie , Pneumopathie virale/épidémiologie , Bangladesh/épidémiologie , Betacoronavirus , COVID-19 , Contrôle des maladies transmissibles/organisation et administration , Infections à coronavirus/prévention et contrôle , Recommandations comme sujet , Humains , Pandémies/prévention et contrôle , Pneumopathie virale/prévention et contrôle , Facteurs de risque , SARS-CoV-2
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE